Small-sized low-density lipoproteins of subclass B from patients with end-stage renal disease effectively augment tumor necrosis factor-α-induced adhesive properties in human endothelial cells

American Journal of Kidney Diseases

Volumn 39, Issue 5, 2002, Pages 972-984

  Ambrosch, Andreas ^a   Müller, Regina ^a   Freytag, Claudia ^a   Borgmann, Stefan ^a   Kraus, Jürgen ^a   Dierkes, Jutta ^a   Neumann, Klaus H ^a   König, Wolfgang ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Activator protein 1 (AP 1); Adhesion molecules; End stage renal disease (ESRD); Human umbilical vein endothelial cells (HUVECs); Hypertriglyceridemia; Low density lipoprotein (LDL); Nuclear factor B (NF B); Subclass B phenotype

Indexed keywords

CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATHEROGENESIS; BIOLOGICAL MODEL; CELL ADHESION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY FAILURE; MALE; MOLECULAR SIZE; MONOCYTE; OXIDATIVE STRESS; PHENOTYPE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN METABOLISM; UMBILICAL VEIN;

EID: 0036240580     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.32771     Document Type: Article

References (54)

1. Lipoprotein structural abnormalities in chronic renal failure with and without hemodialysis
2. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure
3. Low density lipoprotein subclass patterns and risk of myocardial infarction
4. Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: Changes with metabolic control
5. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small but not in triglyceride-rich LDL of normal size
6. Oxidation of low-density lipoproteins from patients with renal failure or renal transplants
7. Adherence of neutrophils to cultured human microvascular endothelial cells: Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p 150,95 glycoprotein family
8. Endothelial-leukocyte adhesion molecules
9. Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion
10. Atherogenic levels of low-density lipoprotein increase endocytotic activity in cultured human endothelial cells
11. Atherogenic concentrations of low density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic acid products
12. Native low-density lipoprotein: Endothelial cell recruitment of mononuclear cells
13. Effect of low density lipoprotein on endothelial cell membrane fluidity and mononuclear cell attachment
14. Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells
15. Effect of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells
16. Balance between IL-1β TNFα and their specific inhibitors in chronic renal failure and maintenance dialysis
17. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure
18. Compositional and functional changes of low-density lipoprotein during hemodialysis in patients with ESRD
19. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia in fibroblasts
20. Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: A potential mechanism for increased atherogenicity
21. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
22. Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells
23. Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cells with a single-step fluorometric assay
24. Vascular endothelial growth factor activates nuclear factor-κB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells
25. Differences in receptor binding of LDL subfractions
26. What are the cause and consequences of the chronic inflammatory state in chronic dialysis patients?
27. Some metabolic characteristics of low-density lipoprotein subfractions, LDL-1 and LDL-2: In vitro and in vivo studies
28. Discrete subspecies of human low density lipoproteins are heterogenous in their interaction with cellular LDL receptor
29. Ligand size as a determinant of catabolism by the low density lipoprotein pathway
30. Differences in receptor binding of LDL subfractions
31. Noninsulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients
32. The influence of triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells
33. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein
34. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells
35. Expression of intercellular adhesion molecule 1 in atherosclerotic plaques
36. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions
37. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease
38. Characterization of the promoter for vascular cell adhesion molecule 1
39. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
40. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1
41. LDL induces transcription factor activator protein-1 in human endothelial cells
42. The jun proto-oncogene is positively autoregulated by its product
43. A cytokine-responsive IKB kinase that activates the transcription factor NF-KB
44. IL-4 synergistically with I1-1 beta promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecules
45. Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth
46. Endothelial interferon regulatory factor I cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1
47. Role of activating activator protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha
48. Induction of vascular cell adhesion molecule-1 by low-density lipoprotein
49. Protein kinase C-activated oxidant generation in endothelial cells signals intercellular adhesion molecule-1 gene transcription
50. LDL stimulates mitogen-activated protein kinase phosphatase-1 expression, independent of LDL receptors in vascular smooth muscle cells
51. Lipoprotein promotes caveolin-1 and ras translocation to caveolae. Role of cholesterol in endothelial signaling
52. Endothelial vasodilatator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes
53. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelial-dependent and independent vasodilation in patients with type 2 diabetes